UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000030082 |
|---|---|
| Receipt number | R000034345 |
| Scientific Title | Follow up analysis of phase III study of gefitinib versus erlotinib in patients with advanced lung adenocarcinoma. |
| Date of disclosure of the study information | 2017/11/22 |
| Last modified on | 2023/01/10 09:52:40 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/11/22 16:07:08 | ||
| 2 | Update | 2017/11/22 16:07:54 | Public title |
|
| 3 | Update | 2018/02/05 14:56:49 | Recruitment status |
|
| 4 | Update | 2022/03/01 13:31:57 | Recruitment status Date of IRB Last follow-up date |
|
| 5 | Update | 2023/01/10 09:52:40 | Recruitment status |
